Prelude Therapeutics, Inc. (PRLD)
3.65
+0.12
(+3.40%)
USD |
NASDAQ |
Oct 21, 16:00
3.65
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Net Income (Annual) : -99.50M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -99.50M |
| December 31, 2024 | -127.17M |
| December 31, 2023 | -121.83M |
| December 31, 2022 | -115.44M |
| Date | Value |
|---|---|
| December 31, 2021 | -111.69M |
| December 31, 2020 | -56.93M |
| December 31, 2019 | -27.57M |
| December 31, 2018 | -14.68M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Q32 Bio, Inc. | 29.82M |
| Intellia Therapeutics, Inc. | -412.69M |
| Twist Bioscience Corp. | -77.67M |
| Beam Therapeutics, Inc. | -79.99M |
| Revolution Medicines, Inc. | -1.131B |